NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

A Clinical Study of ONO-1110 in Patients With Fibromyalgia

NCT06752590

CompletedPhase 2

Sponsor: Ono Pharmaceutical Co., Ltd.

Conditions: Fibromyalgia

Interventions: ONO-1110, Placebo

Countries: Japan

To Evaluate the Efficacy and Safety of ONO-1110 in Patients with Fibromyalgia

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

* Japanese (both sexes)
* Outpatient
* Patients who are considered capable of understanding the study procedures and completing the pain diary and questionnaires appropriately by the investigator (sub-investigator)
* Patients who meet the American College of Rheumatology Fibromyalgia Criteria

Exclusion Criteria:

* Patients with inflammatory arthritis, infectious arthritis, or autoimmune disease
* Patients with pain other than FM that may affect assessments in this study
* Patients with a past history of or concurrent neurologic diseases that may affect assessments in this study
* Patients with a past history of or concurrent malignant tumor within 3 years
* Patients who are pregnant, nursing, or possibly pregnant, or intending to become pregnant during the study period.

Locations (30)

Nagakute, Aichi-ken, Japan
Nagoya, Aichi-ken, Japan
Yotsukaidō, Chiba, Japan
Fukuoka, Fukuoka, Japan
Sapporo, Hokkaido, Japan
Katō, Hyōgo, Japan
Morioka, Iwate, Japan
Kawasaki, Kanagawa, Japan
Yokohama, Kanagawa, Japan
Miyazaki, Miyazaki, Japan
Ōmura, Nagasaki, Japan
Ōita, Oita Prefecture, Japan
Okayama, Okayama-ken, Japan
Osaka, Osaka, Japan
Osaka, Osaka, Japan
Shizuoka, Shizuoka, Japan
Tokyo, Tokyo, Japan
Tokyo, Tokyo, Japan
Tokyo, Tokyo, Japan
Tokyo, Tokyo, Japan
Tokyo, Tokyo, Japan
Tokyo, Tokyo, Japan
Tokyo, Tokyo, Japan
Tokyo, Tokyo, Japan
Tokyo, Tokyo, Japan
Tokyo, Tokyo, Japan
Tokyo, Tokyo, Japan
Toyama, Toyama, Japan
Fukuoka, Japan
Tokyo, Japan